Hemocompatibility of drug-eluting coronary stents coated with sulfonated poly (styrene-block-isobutylene-block-styrene)

Biomaterials

Volumn 33, Issue 33, 2012, Pages 8204-8212

  Zhu, Jin Zhou ^a   Xiong, Xiao Wei ^a   Du, Run ^a   Jing, Ya Jun ^a   Ying, Yuan ^b   Fan, Xiao Ming ^c   Zhu, Tian Qi ^a   Zhang, Rui Yan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Drug eluting stent; Hemocompatibility; Late stent thrombosis; Poly(styrene block isobutylene block styrene); Re endothelialization

Indexed keywords

DRUG-ELUTING STENTS; HEMOCOMPATIBILITY; LATE STENT THROMBOSIS; POLY(STYRENE-BLOCK ISOBUTYLENE-BLOCK-STYRENE); RE-ENDOTHELIALIZATION;

ARTIFICIAL ORGANS; BIOCOMPATIBILITY; BUTENES; ENDOTHELIAL CELLS; HEART; PLASTIC COATINGS; POLYMERS; RHENIUM; STYRENE;

STENTS;

ACETYLSALICYLIC ACID; CLOPIDOGREL; POLY(STYRENE BLOCK ISOBUTYLENE BLOCK STYRENE); POLYMER; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; BIOCOMPATIBILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY STENT; DRUG ELUTING STENT; FOLLOW UP; HEMOLYSATE; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ALKENES; ANIMALS; CELLS, CULTURED; DRUG-ELUTING STENTS; ERYTHROCYTES; HEMOLYSIS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICROSCOPY, ELECTRON, SCANNING; POLYMERS; STYRENE; SWINE;

SUS;

EID: 84866169486     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.07.066     Document Type: Article

References (27)

1. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002, 346:1773-1780.
2. Ong A.T., Hoye A., Aoki J., van Mieghem C.A., Rodriguez Granillo G.A., Sonnenschein K., et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005, 45:947-953.
3. Zimarino M., Renda G., Maddestra N., De Caterina R. Late coronary thrombosis after drug-eluting stent: stent vs. patient-driven prescription of aspirin-clopidogrel combination. Thromb Haemost 2004, 92:668-669.
4. Joner M., Finn A.V., Farb A., Mont E.K., Kolodgie F.D., Ladich E., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006, 48:193-202.
5. Nebeker J.R., Virmani R., Bennett C.L., Hoffman J.M., Samore M.H., Alvarez J., et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the research on adverse drug events and reports (RADAR) project. J Am Coll Cardiol 2006, 47:175-181.
6. Guagliumi G., Farb A., Musumeci G., Valsecchi O., Tespili M., Motta T., et al. Images in cardiovascular medicine. Sirolimus-eluting stent implanted in human coronary artery for 16 months: pathological findings. Circulation 2003, 107:1340-1341.
7. Pinchuk L., Wilson G.J., Barry J.J., Schoephoerster R.T., Parel J.M., Kennedy J.P. Medical applications of poly(styrene-block-isobutylene-block-styrene) (" SIBS" ). Biomaterials 2008, 29:448-460.
8. Edited by ASMI Materials and coatings for medical devices: cardiovascular 2009, ASM International.
9. Huang R.Y.M., Shao P.H., Burns C.M., Feng X. Sulfonation of poly(ether ether ketone) (PEEK): kinetic study and characterization. J Appl Polym Sci 2001, 82:2651-2660.
10. Shen L.Q., Xu Z.K., Yang Q., Sun H.L., Wang S.Y., Xu Y.Y. Preparation and characterization of sulfonated polyetherimide/polyetherimide blend membranes. J Appl Polym Sci 2004, 92:1709-1715.
11. Xing P.X., Robertson G.P., Guiver M.D., Mikhailenko S.D., Wang K.P., Kaliaguine S. Synthesis and characterization of sulfonated poly(ether ether ketone) for proton exchange membranes. J Memb Sci 2004, 229:95-106.
12. Elabd Y.A., Napadensky E. Sulfonation and characterization of poly (styrene-isobutylene-styrene) triblock copolymers at high ion-exchange capacities. Polymer 2004, 45:3037-3043.
13. Shih M.F., Shau M.D., Chang M.Y., Chiou S.K., Chang J.K., Cherng J.Y. Platelet adsorption and hemolytic properties of liquid crystal/composite polymers. Int J Pharm 2006, 327:117-125.
14. Alexis F., Venkatraman S.S., Rath S.K., Boey F. In vitro study of release mechanisms of paclitaxel and rapamycin from drug-incorporated biodegradable stent matrices. J Control Release 2004, 98:67-74.
15. Schwartz R.S., Huber K.C., Murphy J.G., Edwards W.D., Camrud A.R., Vlietstra R.E., et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992, 19:267-274.
16. Kornowski R., Hong M.K., Tio F.O., Bramwell O., Wu H., Leon M.B. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998, 31:224-230.
17. Wennberg A., Hensten-Pettersen A. Sensitivity of erythrocytes from various species to in vitro hemolyzation. J Biomed Mater Res 1981, 15:433-435.
18. Kamath K.R., Barry J.J., Miller K.M. The Taxus drug-eluting stent: a new paradigm in controlled drug delivery. Adv Drug Deliv Rev 2006, 58:412-436.
19. Sousa J.E., Costa M.A., Abizaid A.C., Rensing B.J., Abizaid A.S., Tanajura L.F., et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 2001, 104:2007-2011.
20. McFadden E.P., Stabile E., Regar E., Cheneau E., Ong A.T., Kinnaird T., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004, 364:1519-1521.
21. Kotani J., Awata M., Nanto S., Uematsu M., Oshima F., Minamiguchi H., et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 2006, 47:2108-2111.
22. Virmani R., Guagliumi G., Farb A., Musumeci G., Grieco N., Motta T., et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?. Circulation 2004, 109:701-705.
23. Windecker S., Serruys P.W., Wandel S., Buszman P., Trznadel S., Linke A., et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet 2008, 372:1163-1173.
24. Garg S., Serruys P.W. Coronary stents: looking forward. J Am Coll Cardiol 2010, 56:S43-S78.
25. Chen J.L., Gao L.J., Yang Y.J., Li J.J., Qiao S.B., Xu B., et al. Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results. Chin Med J (Engl) 2010, 123:778-781.
26. Dou K.F., Xu B., Yang Y.J., Chen J.L., Qiao S.B., Wang Y., et al. Comparison of long-term clinical outcome after successful implantation of firebird sirolimus- and Taxus paclitaxel-eluting stents in Chinese population: analysis of a large single center registry. Chin Med J (Engl) 2010, 123:810-815.
27. Wilson G.J., Polovick J.E., Huibregtse B.A., Poff B.C. Overlapping paclitaxel-eluting stents: long-term effects in a porcine coronary artery model. Cardiovasc Res 2007, 76:361-372.